Efficacy and Safety of Biologics and Small Molecules for Moderate-to-Severe Hidradenitis Suppurativa: A Systematic Review and Network Meta-Analysis

Background: Treatment of hidradenitis suppurativa (HS) is difficult and current guidelines are based mainly on expert opinion and non-randomized controlled trials. Recently, there have been some targeted therapies using uniform primary endpoints for outcome assessment. Objective: Recommendations can...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ya-Chu, Hung, Chen-Yiu, Tsai, Tsen-Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224469/
https://www.ncbi.nlm.nih.gov/pubmed/37242593
http://dx.doi.org/10.3390/pharmaceutics15051351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224469/
https://www.ncbi.nlm.nih.gov/pubmed/37242593
http://dx.doi.org/10.3390/pharmaceutics15051351

Ejemplares similares